Oncolytic virus CF33-hNIS monotherapy for the treatment of gastrointestinal (GI) malignancies.

Authors

null

Daneng Li

City of Hope National Comprehensive Cancer Center, Duarte, CA

Daneng Li , Anthony F. Shields , Hirva Mamdani , Jennifer Leddon , Patrick M. Travis , Colt A. Egelston , Oscar Colunga Flores , Stanley R. Hamilton , Janet Austria , Amanda Seiz , Sharon Yavrom , John Chong Han Byon , Paul Paul Woodard , Grey A Wilkinson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05346484

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 749)

DOI

10.1200/JCO.2024.42.3_suppl.749

Abstract #

749

Poster Bd #

M4

Abstract Disclosures

Similar Posters

First Author: Judy S. Wang

First Author: Susanna Varkey Ulahannan